SenzaGen
5.42 SEK
+0.37 %
Less than 1K followers
SENZA
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for SenzaGen
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 2.7 | 8.0 | 15.4 | 41.8 | 49.9 | 57.7 | 58.0 |
| growth-% | 192.1 % | 93.8 % | 170.8 % | 19.4 % | 15.7 % | 0.5 % | |
| EBITDA | -34.9 | -27.1 | -31.5 | -15.7 | -10.9 | -5.6 | - |
| EBIT | -37.9 | -27.1 | -31.5 | -25.1 | -22.5 | -19.0 | -11.6 |
| Profit before taxes | -37.7 | -27.2 | -31.4 | -25.0 | -22.0 | -18.4 | -11.8 |
| Net income | -50.2 | -27.2 | -31.3 | -24.9 | -22.1 | -17.9 | -11.6 |
| EPS | -3.11 | -1.27 | -1.35 | -1.03 | -0.91 | -0.65 | -0.39 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -1,282.6 % | -340.5 % | -204.5 % | -37.6 % | -21.9 % | -9.7 % | |
| EBIT-% | -1,392.3 % | -340.5 % | -204.5 % | -60.1 % | -45.1 % | -32.8 % | -20.1 % |
| ROE | -37.4 % | -25.2 % | -28.4 % | -27.8 % | -32.7 % | -20.6 % | -14.9 % |
| ROI | -35.1 % | -24.4 % | -23.4 % | -20.8 % | -22.7 % | -16.0 % | -10.0 % |